Literature DB >> 27292783

Beneficial Effects of the Amino Acid Glycine.

Israel Pérez-Torres, Alejandra María Zuniga-Munoz, Veronica Guarner-Lans1.   

Abstract

Glycine is the smallest non-essential, neutral and metabolically inert amino acid, with a carbon atom bound to two hydrogen atoms, and to an amino and a carboxyl group. This amino acid is an essential substrate for the synthesis of several biologically important biomolecules and compounds. It participates in the synthesis of proteins, of the tripeptide glutathione and in detoxification reactions. It has a broad spectrum of anti-inflammatory, cytoprotective and immunomodulatory properties. To exert its actions, glycine binds to different receptors. The GlyR anion channel is the most studied receptor for glycine. However, there are GlyR-independent mechanisms for glycine cytoprotection and other possible binding molecules of glycine are the NMDA receptor and receptors GlyT1 and GlyT2. Although, in humans, the normal serum level of glycine is approximately 300 μM, increasing glycine intake can lead to blood levels of more than 900 μM that increase its benefic actions without having harmful side effects. The herbal pesticide glyphosate might disrupt glycine homeostasis. Many in vitro studies involving different cell types have demonstrated beneficial effects of the addition of glycine. Glycine also improved conditions of isolated perfused or stored organs. In vivo studies in experimental animals have also tested glycine as a protector molecule and some studies on the beneficial effects of glycine after its clinical application have been done. Although at high-doses, glycine may cause toxic effects, further studies are needed to investigate the safe range of usage of this aminoacid and to test the diverse routes of administration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27292783     DOI: 10.2174/1389557516666160609081602

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Oxidative stress delays development and alters gene expression in the agricultural pest moth, Helicoverpa armigera.

Authors:  Nonthakorn Beatrice Apirajkamol; Bill James; Karl H J Gordon; Tom K Walsh; Angela McGaughran
Journal:  Ecol Evol       Date:  2020-04-29       Impact factor: 2.912

2.  Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Authors:  Shunji Oshima; Sachie Shiiya; Yasunori Nakamura
Journal:  Nutrients       Date:  2019-03-06       Impact factor: 5.717

Review 3.  Glycine Supplementation Ameliorates Retinal Neuronal Damage in an Experimental Model of Diabetes in Rats: A Light and Electron Microscopic Study.

Authors:  Soghra Gholami; Younes Kamali; Mohammad Reza Rostamzad
Journal:  J Ophthalmic Vis Res       Date:  2019-10-24

Review 4.  Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications.

Authors:  Edgar Del Carpio; Lino Hernández; Carlos Ciangherotti; Valentina Villalobos Coa; Lissette Jiménez; Vito Lubes; Giuseppe Lubes
Journal:  Coord Chem Rev       Date:  2018-06-21       Impact factor: 22.315

Review 5.  Invited Review: Maintain or Improve Piglet Gut Health around Weanling: The Fundamental Effects of Dietary Amino Acids.

Authors:  Shengfa F Liao
Journal:  Animals (Basel)       Date:  2021-04-13       Impact factor: 2.752

6.  A synthetic BBB-permeable tripeptide GCF confers neuroprotection by increasing glycine in the ischemic brain.

Authors:  Juan Chen; Yang Zhuang; Ya Zhang; Huabao Liao; Rui Liu; Jing Cheng; Zhifeng Zhang; Jiangdong Sun; Jingchen Gao; Xiyuran Wang; Shujun Chen; Liang Zhang; Fengyuan Che; Qi Wan
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

7.  Combined Supplementation with Glycine and Tryptophan Reduces Purine-Induced Serum Uric Acid Elevation by Accelerating Urinary Uric Acid Excretion: A Randomized, Single-Blind, Placebo-Controlled, Crossover Study.

Authors:  Shunji Oshima; Sachie Shiiya; Yasunori Nakamura
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

Review 8.  Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer.

Authors:  Yu Takeda; Ryota Chijimatsu; Andrea Vecchione; Takahiro Arai; Toru Kitagawa; Ken Ofusa; Masami Yabumoto; Takaaki Hirotsu; Hidetoshi Eguchi; Yuichiro Doki; Hideshi Ishii
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.